Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays

Laryngoscope

Volumn 106, Issue 5, 1996, Pages 605-609

  Graf, Peter ^a   Hallén, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; OXYMETAZOLINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; INTRANASAL DRUG ADMINISTRATION; LONG TERM EXPOSURE; NORMAL HUMAN; NOSE CONGESTION; NOSE MUCOSA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; BENZALKONIUM COMPOUNDS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL DECONGESTANTS; NASAL MUCOSA; OXYMETAZOLINE; PLACEBOS; PRESERVATIVES, PHARMACEUTICAL; RHINITIS;

EID: 0029919277     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-199605000-00016     Document Type: Article

References (27)

1. Hünerman T. Kritisches zur Schupfenterapie. Deutsche Med Wochenschr. 1942;68:580-581.
2. Gollom J. The problem of nasal medication with particular reference to privine HCL. Can Med Assoc J. 1944;51:123-126.
3. Kully B. The use and abuse of nasal vasoconstrictor medication. JAMA. 1945;127:307-310.
4. Evaluation of a nasal decongestant. Oxymetazoline hydrochloride (Afrin). JAMA. 1965;193:133.
5. Rijntjes E. Nose-Drop Abuse, a Functional and Morphological Study. Leiden, The Netherlands: University of Leiden, 1985. Thesis.
6. Graf P, Juto JE. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline. ORL J Otorhinolaryngol Relat Spec. 1994;56:131-134.
7. Graf P, Juto JE. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling. Rhinology. 1995;33:14-17.
8. Petruson B, Hansson H-A, Function and structure of the nasal mucosa after 6 weeks' use of nose-drops. Acta Otolaryngol (Stockh). 1982;94:563-569.
9. Petruson B. Treatment with xylometazoline (Otrivin) nose-drops over a six-week period. Rhinology. 1981;19:167-172.
10. Åkerlund A, Bende M. Sustained use of xylometazoline nosedrops aggravates vasomotor rhinitis. Am J Rhinol. 1991;5:157-160.
11. Batts A, Marriot C, Martin G, et al. The effect of some preservatives used in nasal preparations on mucociliary clearance. J Pharm Pharmacol. 1989;41:156-159.
12. Tönjum A. Permeability of rabbit corneal epithelium to horseradish peroxidase after the influence of benzalkonium chloride. Acta Ophthalmol (Copenh). 1975;53:335-347.
13. Miszkiel K, Beasley R, Holgate ST. The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma. Br J Clin Pharmacol. 1988;26:295-301.
14. Yaniv TH. Nasal irritation from eye drops. Am J Rhinol. 1994; 8:153-155.
15. Graf P, Hallén H, Juto JE. Benzalkonium chloride in a decongestant spray aggravates rhinitis medicamentosa in healthy volunteers. Clin Exp Allergy. 1995;25:395-400.
16. Hallén H, Graf P. Benzalkonium chloride in nasal spray has a long-lasting effect on the nasal mucosa. Clin Exp Allergy. 1995;25:401-405.
17. Juto JE, Lundberg C. An optical method for determining changes in mucosal congestion in the nose in man. Acta Otolaryngol (Stockh). 1982;94:149-156.
18. Von Knothe J, Rietshel M. Vergleichende Untersuchungen zum therapeutischen Effekt verschiedener Antirhinitika. Deutsche Gesundheitswesen. 1976;31:569-573.
19. Åkerlund A, Klint T, Olén L, et al. Nasal decongestant effect of oxymetazoline in the common cold: an objective dose-response study in 106 patients. J Laryngol Otol. 1989;103:743-746.
20. Lundblad L, Brodin E, Lundberg JM, et al. Effects of nasal capsaicin pretreatment and cryosurgery on sneezing reflexes in neurogenic plasma extravasation, sensory and sympathetic neurons. Acta Otolaryngol(Stockh). 1985;100:117-127.
21. Stjärne P, Lundblad L, Lundberg JM, et al. Capsaicin and nicotine-sensitive afferent neurons and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol. 1989;96:693-701.
22. Wolfe G, Loidolt D, Saria A, et al. Änderungen des nasalen Volymsstromes nach lokaler Applikation des Neuropeptides substanz-P und von Capsaicin. Laryngorhinootologie. 1987; 66:412-415.
23. Elwany S, Stephanos W. Rhinitis medicamentosa. An experimental histopathological and histochemical study. ORL J Otorhinolaryngol Relat Spec. 1983;45:187-194.
24. Stride R. Nasal decongestant therapy. Br J Clin Pract. 1967; 21:541-548.
25. Hallén H, Juto JE. A test for objective diagnosis of nasal hyperreactivity. Rhinology. 1993;31:23-25.
26. Graf P, Hallén H, Juto JE. The pathophysiology and treatment of rhinitis medicamentosa. Clin Otolaryngol. 1995;20:224-229.
27. Hallén H, Juto JE. An objective method to record changes in nasal reactivity during treatment of non-allergic nasal hyperreactivity. ORL J Otorhinolaryngol Relat Spec. 1994;56: 92-95.